drugset
drugset / Trial / NCT07547995

A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.

NCT07547995 ↗

Phase 2 Not yet recruiting 111 enrolled Changchun GeneScience Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to evaluate the efficacy and safety of GenSci048 compared with placebo in subjects with active non-infectious uveitis.

Timeline

Start
2026-06-18
Primary completion
2027-12-14
Completion
2028-01-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Genakumab Monoclonal antibody — Subcutaneous

Indications

uveitis